Trial Profile
A multicenter, prospective, randomized controlled trial evaluating efficacy of intravesical chemotherapy using pirarubicin for patients with non-muscle invasive bladder carcinoma with low or intermediate risk.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Pirarubicin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 30 Jun 2016 New trial record